Purchase Order DOCSB134117SE0199
- Not listed
- This is a $90,997.20 firm fixed-price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the supply of an MISEQ I100 PLUS SYSTEM, with a period of performance running through December 12, 2025. This contract was not set aside for any specific business type. Illumina holds several other federal Indefinite...
- This is a $141,129.90 firm fixed price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian agency, to Illumina, Inc. for the provision of an ILLUMINA MISEQ FGX sequencing system. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has provided similar products and services to support genomic research and diagnostics for federal agencies like the NIH, CDC,...
- This is a firm fixed price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc. for the provision of sequencing instrument consumables. The contract has a total ceiling value of $94,539.25 and a period of performance through June 30, 2016. Illumina, a manufacturer of genetic sequencing instruments and reagents, has been a prime contractor on prior federal awards supporting genomic sequencing and analysis for...
- This is a firm fixed price purchase order awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc. for the provision of Illumina library preparation and sequencing reagents/consumables. The contract has a ceiling value of $148,435.10 and a completion date of March 31, 2017. It is not a set-aside contract. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has provided similar goods and...
- This is a $127,989.57 firm fixed-price delivery order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing technologies. The contract has a period of performance ending on July 30, 2026. Illumina, a for-profit manufacturer, has been awarded multiple federal contracts and blanket purchase agreements to provide a range of genomic sequencing platforms,...
- This is a firm fixed-price purchase order awarded by the National Institute of Standards and Technology (NIST), a civilian agency, to Illumina, Inc. for ILLUMINA SEQUENCING INSTRUMENT SUPPORT AGREEMENTS. The award has a ceiling value of $100,208.68 and an ultimate completion date of September 15, 2016. Illumina, a for-profit manufacturer of sequencing and array-based solutions for genetic and genomic analysis, has provided a range of sequencing instruments, reagents, and related services to...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
- This $95,931.00 firm fixed price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the provision of a MiSeq System, a genetic analysis platform used in life science research, applied markets, and molecular diagnostics. Illumina has a history of providing sequencing systems and consumables to support...
- This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, part of the National Institutes of Health, to Illumina, Inc. The total ceiling value of the contract is $16,851.34 with a final completion date of September 1, 2025. Illumina, a for-profit manufacturer of genomic sequencing and analysis instruments and reagents, has been awarded this contract to provide a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as...
- The Department of Commerce National Institute of Standards and Technology (NIST) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of two (2) Illumina DNA sequencing instruments that are compatible with the validated protocols developed by NIST, in accordance with the stated requirements. The potential value of the contract is $100,878.00, and it was...
This is a firm fixed-price purchase order awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for a service agreement to provide Illumina HiSeq and MiSeq equipment, with a ceiling value of $87,393.52 and a completion date of September 15, 2021. The contract does not have a set-aside designation. Illumina is a for-profit organization and manufacturer of goods that has been awarded numerous prime federal contracts and grants by agencies such as the NIH, CDC, USDA, VA, and FDA to provide advanced genomic sequencing platforms, reagents, and related services. The contract is part of Illumina's existing Blanket Purchase Agreement and Indefinite Delivery Contract vehicles with the Department of Veterans Affairs, which enable the flexible procurement of their products and services across multiple VA facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P25002 | Funding Only Action | 0$ | 5/30/25 | |
| 3 | Exercise an Option | $13.9k | 4/12/18 | |
| 2 | Exercise an Option | $12.4k | 12/15/17 | |
| 1 | Funding Only Action | $0 | 7/13/17 | |
| Not listed | Not listed | $31.6k | 7/12/17 |